Evidence map›Paper›PMID 28720847›Full record

ArticleScientific reports2017

The glycointeractome of serogroup B Neisseria meningitidis strain MC58.

Tsitsi D Mubaiwa, Lauren E Hartley-Tassell, Evgeny A Semchenko, Freda E-C Jen, Yogitha N Srikhanta, Christopher J Day, Michael P Jennings, Kate L Seib

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Role of Glycosylation in Infectious Diseases.Advances in experimental medicine and biology · 2021
    Review
  10. Article
  11. Receptor recognition by meningococcal type IV pili relies on a specific complexProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Review
  13. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  14. Article
  15. Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery.Database : the journal of biological databases and curation · 2019
    Review
  16. Article
  17. Glycointeractions in bacterial pathogenesis.Nature reviews. Microbiology · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tsitsi D MubaiwaInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Lauren E Hartley-TassellInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Evgeny A SemchenkoInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Freda E-C JenInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Yogitha N SrikhantaInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Christopher J DayInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Michael P JenningsInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia. m.jennings@griffith.edu.au.
Kate L SeibInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia. k.seib@griffith.edu.au.
Griffith University · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis express numerous virulence factors that enable it to interact with diverse microenvironments within the host, during both asymptomatic nasopharyngeal colonization and invasive disease. Many of these interactions involve bacterial or host glycans. In order to characterise the meningococcal glycointeractome, glycan arrays representative of structures found on human cells, were used as a screening tool to investigate host glycans bound by N. meningitidis. Arrays probed with fluorescently labelled wild-type MC58 revealed binding to 223 glycans, including blood group antigens, mucins, gangliosides and glycosaminoglycans. Mutant strains lacking surface components, including capsule, lipooligosaccharide (LOS), Opc and pili, were investigated to identify the factors responsible for glycan binding. Surface plasmon resonance and isothermal calorimetry were used to confirm binding and determine affinities between surface components and host glycans. We observed that the L3 LOS immunotype (whole cells and purified LOS) bound 26 structures, while L8 only bound 5 structures. We further demonstrated a direct glycan-glycan interaction between purified L3 LOS and Thomsen-Friedenreich (TF) antigen, with a K

Indexed as

CalorimetryGene Knockout TechniquesGlycomicsHost-Pathogen InteractionsHumansMeningococcal InfectionsMutationNeisseria meningitidis, Serogroup BPolysaccharidesSurface Plasmon ResonanceVirulence FactorsPolysaccharidesVirulence Factors

Identifiers

PMID28720847
PMCPMC5515891
OpenAlexW2735021552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.